Presentation is loading. Please wait.

Presentation is loading. Please wait.

Evaluating Australia‘s National Strategy for Quality Use of Medicines

Similar presentations


Presentation on theme: "Evaluating Australia‘s National Strategy for Quality Use of Medicines"— Presentation transcript:

1 Evaluating Australia‘s National Strategy for Quality Use of Medicines
Results of indicator measurements

2 Quality Use of Medicines
National Strategy for Quality Use of Medicines established 1992

3 The Vision Partnership Awareness Enabling Maintaining Government
Policy development Health professionals Government Industry Consumers Partnership Maintaining Facilitation and co-ordination Objective information and ethical promotion Healthy Consumers Education & training Services and interventions Routine data collection

4 The Original Vision for QUM (1992)
National Facilitation & Co-ordination Objective Information Education & Training Consumer Services Provider Services Campaigns Australian National Formulary National Therapeutic Guidelines Australian Prescriber Consumer Medicines Information Consumer education for self-reliance School kits & adult learning Core curricula for providers Ethical promotion Undergraduate, postgraduate & continuing ed’n Multidisciplinary team approach Awareness Motivation Confidence Medication records Compliance aids Disposal of unwanted medicines Stimulate teamwork Academic detailing Models of practice Audit & feedback Critical appraisal of promotion General awareness Elderly Asthma Analgesics Out-of-date medication Targeted Grants for Further Development Medication review

5 Evaluation Indicators were developed in1993
to mirror the national strategy framework address all key strategies, all partners, all stages of learning monitor process, impact and outcome (implementation and effect)

6 Are there nationally recognised therapeutic guidelines?
Process Indicator: Are there nationally recognised therapeutic guidelines? Therapeutic guidelines now cover ten therapeutic areas 60% general practitioners report using antibiotic guidelines

7 Process Indicator: Is there Consumer Medicines Information?
Consumer medicines information developed for over 1900 products 60% of consumers report receiving consumer medicines information with their last new medicine

8 Process Indicator: Are medication review services available?
1998: services for aged care facilities 127,000 (85%) residents in Australia provided with the service in 2002 2001: funding for community services 1294 (~10%) pharmacists accredited, 3272 (~65%) pharmacies registered to provide the service 22,000 home visits in 2003

9 Guidelines for medication management in aged care facilities
Process Indicator: Are there guidelines for medication management in aged-care facilities? Guidelines for medication management in aged care facilities 3rd edition 2003 ~40,000 distributed

10 Process Indicator: Is there a medication disposal service?
Return Unwanted Medicines, established 1998 250 tonnes of medication collected in 2003

11 Process Indicator: Is there Quality Use of Medicines education for health professionals?
National Prescribing Service Newsletters & prescribing feedback over 20,000 GPs Locally based-facilitators Academic detailing, Clinical audits, Case studies, over 50% of GPs participating

12 Impact indicators: Percent of consumers asking questions of their doctor when prescribed a new medicine

13 Impact indicator: changes in medication use
Ratio of inhaled corticosteroids to short acting bronchodilators for asthma

14 Outcome indicators: changes in hospitalisation rates
Hospitalisation rates for asthma

15 Where are we up to?

16 Partnership Awareness Enabling Maintaining Healthy Consumers
National Health Policy National Medicines Policy Federal, State & Territory QUM Policies Integrated & consistent Awareness Enabling Maintaining Medication Review funds Co-ordination, facilitation mechanism Funding & evaluation process Dialogue & collaboration All involved & endorsed Therapeutic Guidelines National Therapeutics Bulletin National Formulary CMI Codes of Conduct Healthy Consumers National Prescribing Service Partnership QUM Curricula ( all groups) Complementary Health Care Information technology Other health policies Media Private health industry ADR reporting (HP’s & consumers) Medication management aids (funded) Discharge planning standards Medication review services Medication disposal services Drug utilisation feed back Campaigns National Media Liaison Strategy Drug use audits National Data set

17 Lessons learned Useful for identifying successes and gaps in implementation & informing strategic action plans Articulation of essential activities in the policy document & in manual of indicators has led to prioritisation Continuous feedback through a number of different channels and in a number of different formats has been essential


Download ppt "Evaluating Australia‘s National Strategy for Quality Use of Medicines"

Similar presentations


Ads by Google